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Background: Diffuse oesophageal leiomyomatosis (DOL) is a rare disorder characterized by tumorous overgrowth
of the muscular wall of the oesophagus. DOL is present in 5 % of Alport syndrome (AS) patients. AS is a rare
hereditary disease that involves varying degrees of hearing impairment, ocular changes and progressive
glomerulonephritis leading to renal failure. In DOL-AS patients, the genetic defect consists of a deletion involving the
COL4A5 and COL4A6 genes on the X chromosome.
Case presentation: We report a two-generation family (4 individuals; parents and two children, one male and one
female) with two members (mother and son) affected with oesophageal leiomyomatosis. Signs of potential renal
failure, which characterizes AS, were only apparent in the index patient (son) 2 years and three months after the
initial diagnosis of DOL. Blood DNA from the four family members were submitted to exome sequencing and array
genotyping to perform a genome wide screening for disease causal single nucleotide (SN) and copy number (CN)
variations. Analyses revealed a new 40kb deletion encompassing from intron 2 of COL4A5 to intron 1 of COL4A6 at
Xq22.3. The breakpoints were also identified. Possible confounding pathogenic exonic variants in genes known to be
involved in other extracellular matrices disorders were also shared by the two affected individuals. Meticulous
analysis of the maternal DNA revealed a case of gonosomal mosaicism.
Conclusions: This is the first report of gonadosomal mosaicism associated to DOL-AS
Keywords: Isolated diffuse oesophageal leiomyomatosis, Whole exome sequencing, Copy number variation, COL4A5,
COL4A6, Gonosomal mosaicismBackground
Diffuse oesophageal leiomyomatosis (DOL) is a rare
disorder characterized by tumorous overgrowth of the
muscular wall of the oesophagus. DOL has been described
in 5 % of Alport syndrome (AS) patients reported (DOL-
AS) [1, 2]. AS is a rare hereditary disease that involves
varying degrees of hearing impairment, ocular changes
and progressive glomerulonephritis leading to renal fail-
ure. In DOL-AS patients, the genetic defect consists of a* Correspondence: mmgarcia@hku.hk; huiminxia@hotmail.com
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creativecommons.org/publicdomain/zero/1.0/large deletion involving the COL4A5 and COL4A6 genes
on the X chromosome. Thus, the DOL-AS inheritance
pattern is that of an X-linked dominant disorder where
male patients hemizygous for mutations in COL4A5 are
severely affected, but heterozygous females may display a
broad spectrum of symptoms, ranging from none at all to
severe renal dysfunction. Fusion of repetitive elements lo-
cated within introns of COL4A5 and COL4A6 may result
in long deletions, thus underlying the structural rearrange-
ments observed in DOL-AS patients [3]. The size of the
deletion varies among affected individuals although it usu-
ally spans from intron 2 of COL4A6 to intron 1 COL4A5,
although in some instances, can include the whole
COL4A5 gene [4–8]. The heterogeneity of the deletionsdistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Fig. 1 A photo of the contrast esophagogram
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ments (LINE-1) in these genes suggests a high occurrence
of de novo COL4A5/COL4A6 deletions [3].
As there are large variations in the phenotype and sever-
ity of AS, the disorder may remain undiagnosed. Early
diagnosis of AS is essential as current therapy can slow
the progression to end-stage renal disease which prompts
the need of using molecular tests for more accurate diag-
nosis. Genetic testing is indeed the gold standard.
In this manuscript we present a two-generation family
(4 individuals; parents and two children, one male and
one female) with two members (mother and son) af-
fected with oesophageal leiomyomatosis. Signs of poten-
tial renal failure, that characterizes AS, were only
apparent in the index patient (son) 2 years and three
months after the initial diagnosis of DOL.
In order to provide a molecular signature to help diag-
nose these patients, DNA from all family members was
submitted to whole-exome sequencing (WES) for the
detection of rare single nucleotide variants (SNVs) and
to high density genotyping of common single nucleotide
variants polymorphisms (SNPs) for the detection of vari-
ation in the number of copies of genomic regions (Copy
Number Variants; CNV). This resulted in the identifica-
tion of a new deletion involving two collagen IV chains,
COL4A5 and COL4A6 at Xq22.3. Experiments to define
the precise breakpoints confirmed the deletion spans
from intron 2 of COL4A5 to intron 1 of COL4A6.
Case presentation
Four members of a non-consanguineous Chinese family
were included in the study. The study was approved by
the institutional review board of The University of Hong
Kong together with the Hospital Authority (IRB: UW
07–321). Blood samples were drawn after obtaining
written informed consent. Parents gave written consent
on behalf of their two children.
A 13-year-old boy (index patient) who had previously
been well was admitted to our medical center because of
a history of slowly progressive dysphagia for over 3 years.
He also had intermittent episodes of dyspnea within a
week of admission. There was no other associated symp-
tom. On further questioning, his mother had also been
suffering from mild dysphagia for over 20 years. His
father and younger sister were unaffected.
His body weight was 30 kg and height was 135 cm,
both below the average for this age. Physical examin-
ation was unremarkable. Blood tests showed mild
anemia (Hb 106 g/L, MCV 74.1 fL and MCH 23.3 pg).
Chest X-ray showed a widened mediastinal contour.
Subsequent contrast esophagogram demonstrated nar-
rowing of middle and distal esophagus (Fig. 1). Contrast-
enhanced computed tomography of the chest illustrated
a circumferential soft tissue mass encircling the wholeesophagus diffusely. Due to the long segment of the
esophageal involvement and the possibility of malignant
transformation, right-sided thoracotomy was performed.
Inspection of the thoracic cavity showed a lotus-root-
like esophagus with massive dimension, reaching a max-
imum diameter of 9 cm. The whole esophagus was
resected with reconstruction using a gastric tube intra-
thoracically. The surgical specimen showed three
nodular, well circumscribed nodules of solid, dull
white tumour with a whorled pattern that circumfer-
entially surrounded the whole esophagus (Fig. 2A, B
respectively). Histology showed interlacing bundles of
cytologically benign smooth muscle cells that were posi-
tive for smooth muscle actin (Fig. 3). On the basis of
these findings, the lesion was diagnosed as leiomyomato-
sis. There was no evidence of malignancy histologically.
His mother also underwent esophagogram and compu-
terised tomography (CT) and the results were very simi-
lar to those of her son although X-ray findings do not
necessarily correlate with clinical symptoms. Since she
had no symptoms, she refused further examination or
treatment.
The index patient underwent surgery on January 28th,
2013. On post-operative day one, the patient had
hematuria and mild proteinuria caused by urethral
catheterization. These completely disappear on postop-
erative day four. Uric acid/trioxypurine, creatinine clear-
ance and urea were checked to re-assess renal function
on postoperative day ten. These parameters were con-
sistent with normal renal function. Neither hearing nor
ocular problems were detected in the patient or his
mother.
Overall, the patient’s postoperative course was unre-
markable and he was discharged 23 days after operation.
Fig. 2 Surgical specimen showing three nodular, well circumscribed
nodules (a) of solid, dull white tumour with a whorled pattern that
circumferentially surrounded the whole esophagus (b)
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follow-up. However, hematuria and kidney functional ab-
normalities were detected in the index patient 2 years and
three months (April 2015) after the initial DOL diagnosis.
We proceed with molecular testing by scanning all cod-
ing sequences of the genome for mutations or CNVs that
could account for the phenotype observed in the index pa-
tient and his mother.
Molecular testing
Copy number variations
A genome wide screening on the family was achieved
by using Affymetrix Genome-Wide Human SNP Array
6.0. SNP calls were provided by Center of Genomic
Sciences of the University of Hong Kong. SNP Array
6.0 contains 906,600 SNP probes and 946,000 non-
polymorphic probes that cover 5,677 known CNV re-
gions in Toronto Database of Genomic Variants. Both
types of probes were used for CNV detection and
consanguinity analysis. CNVs were called by two pro-
grams, Affymetrix Genotyping Console 2.1 (GTC) and
QuantiSNP which uses a Hidden Markov Mode. For
the later, CNV calls were based on normalized probe
intensity value against expected intensity in terms of R
ratio (LRR) and relative allelic copy in terms of B allele
frequency (BAF).To retrieve high confidence calls, we filtered out
non-overlapping CNV regions reported by GTC and
QuantiSNP. By intersecting CNV calls from these
two calling algorithms, the false positive rate should
be minimized.
Since Collagen Type IV is frequently associated with
diffuse oesophageal leiomyomatosis, manual screening of
CNVs on these genes was performed and normalized
probe intensities were visualized by Affymetrix Genotyping
Console Browser.
CNV validation
Copy number validation was performed by quantitative
real-time PCR (ABI Prism 7900 Sequence Detection
System; Applied Biosystems) using TaqMan® Copy
Number Assay. The assay was carried out in quadrupli-
cates with the TaqMan® Copy Number Reference Assay
according to the manufacturer’s protocol. The reference
assay targets a copy-number neutral region of RNaseP
gene, serving as an internal standard. We used
Hs01881795_cn which falls on chrX:107,682,713, on
exon 1 of the gene COL4A6. Relative levels of COL4A6
to reference probes were determined using comparative
CT method by ABI CopyCaller. In brief, the mean differ-
ences in cycle threshold (CT) ΔCT between the COL4A6
probe and the reference probes for all replicates were
computed and were subsequently normalized for copy
number prediction.
Detection of the breakpoint
For the detection of the breakpoint, we designed set
of primers spanning ChrX:107685385–107685404 and
ChrX:107644439–107644460 (Additional file 1: Table S1).
The primer sets were used to amplify the region of interest
on the father, affected mother, affected son and the
daughter. The PCR amplified product would encom-
pass the deletion junction. Subsequently, PCR prod-
ucts were sequenced to locate the breakpoint.
Whole exome sequencing
Exome sequencing was performed in the Centre for
Genomic Sciences (CGS) of the Li Ka Shing Faculty of
Medicine of the University of Hong Kong. Briefly,
Illumina’s TruSeq® DNA Sample Prep v.2 and TruSeq®
Exome Enrichment Kits were used for sample prepar-
ation and capture (4 libraries per capture reaction) and
enrichment of targeted sequences, respectively. The kit
captures 62 Mb of the human genome including 20,940
genes, non-coding DNA in flanking regions and regula-
tory elements. The captured DNA was sequenced as
paired-end 100 base reads (PE100) on an Illumina HiSeq
2000, aiming to achieve 121 reads per base (121X) in
average (details on variant calling, quality control and
data analysis can be found in the Additional file 1).
Fig. 3 Haematoxylin and eosin section of the tumour showing intersecting fascicles of cytologically benign smooth muscle cells (a) that are
positive for actin (b) and h-caldesom (c). Magnification X 200
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variant filtration and CNV analysis (see Additional file 1:
for details).
Pathogenicity criteria for rare variants (SNVs and CNVs)
For SNVs, variant pathogenicity was assessed by an
in-house program, KGGSeq. KGGSeq is a software
platform constituted of bioinformatics and statistical
genetics functions making use of valuable biological
resources and knowledge providing a comprehensive
and efficient framework to filter and prioritize gen-
etic variants from whole exome and whole genome
sequencing data [9, 10]. Importantly, KGGSeq inte-
grates “Knowledge” resources from pseudo-genes and
epigenetic databases, biological pathways, OMIM da-
tabases and protein-protein interaction networks to
annotate the genes that harbour any post-QC vari-
ants. KGGSeq also combines deleteriousness predic-
tion (scores and classification) from Polyphen2, Sift,
MutationTaster, GERP conservation scores [11] and
Likelihood ratio.
Since the oesophagus of the two patients were af-
fected, we also assumed that the causal gene is likely to
have high tissue specificity. Therefore annotated the ex-
pression of the genes (in which potentially pathological
variants had been found) in different tissues. For this, we
used RNA-Seq gene expression data from ENCODE and
Gene Expression Omnibus (GEO) database. The expres-
sion values were used for ranking variants, thus, variants
in genes with low expression in esophagus nor involvedin developmental processes were down ranked from the
list.
Only deleterious nonsynonymous, splice-site and
frameshift (SNVs + Indels) variants were further assessed
(N = 11,577). Variants with MAF >0.01 in the control
populations were filtered out under the assumption that
variants underlying this rare disorder would not be fre-
quently found in the general population. A total of 1,013
variants were left for further analysis.
For CNVs, those with >50 % of reciprocal overlap with
the population-based Database of Genomic Variants
were assessed. CNVs with frequency > 1 % were removed
from the analysis.
Finding de-novo mutations
KGGSeq also provides a gene filter for searching de novo
mutations. Since discovery of de novo mutations requires
accurate detection of genotypes of both parents and the
offspring, it is more prone to false positive calls. Thus,
we applied a more stringent filter for de novo mutations.
In addition to the abovementioned filtering criteria
applied on rare variants, the following filtering criteria
were applied. Each de novo mutation requires a read
depth > =8X for a callout. Mutations found in any popu-
lation database were excluded.
Results
We performed WES and CNV analysis on a two-
generation family (4 individuals; parents and two chil-
dren, one male and one female) with two members
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index patient was affected isolated DOL, the index pa-
tient remained free of the signs that accompany DOL in
AS for 2 years and 3 months. Among the genes with var-
iants, we paid particular attention to genes involved in
disorders in which leiomyomatosis is part of their
phenotypic spectrum (AS).
Detection of copy number loss on COL4A5/6
As DOL may be concomitant with Alport syndrome and
all reported DOL-AS cases are associated with muta-
tions in Collagen Type IV genes [5] (in particular with
heterogeneous deletions spanning the COL4A5 and
COL4A6 genes on the X chromosome) [2], we investi-
gated the presence of copy number changes comprising
the Collagen Type IV genes by using the SNP Chip data.
A deletion comprising exons 1 and 2 of COL4A5 and
exon 1 of COL4A6 was called by GTC on the son, but
only a marginal signal was detected in his affected
mother. The deletion spanned from chrX:107,645,023 to
107,685,353 encompassing a total of 40-kb. No such de-
letion was called in any of the healthy family members.
To further confirm the deletion in the mother, we
manually inspected the raw intensity of the SNP chip
and employed exome sequencing coverage for detection
of copy number changes (Additional file 1: Figures S1
and S2). Variations in the number of copies of exonic se-
quences can be detected by analyzing and comparing
the depth of coverage of the exons in the exome sequen-
cing data. The coverage of the targeted exonic regions
were produced by the GATK Depth-of-coverage module.
Plotting the exonic coverage along the COL4A5 and
COL4A6 genes for all family members revealed the
aforementioned deletion in the son and again, a mar-
ginal detection of such deletion was observed in the ma-
ternal exome data.
Validation of candidate CNVs
To validate the candidate CNV, a TaqMan® Copy
Number assay was performed on the 4 family members.
Taqman probes were designed to target exon 1 (on
ChrX:107,682,713) of COL4A6, which is within the
breakpoint detected by SNP Chip. We confirmed a total
loss of COL4A6 exon 1 on the son and a detectable copy
number loss on the affected mother (Additional file 1:
Figure S3).
Breakpoint mapping
To fine map the predicted deletion, iterative rounds of
PCR were performed with different primer sets. One set
(Additional file 1: Table S1) yielded a 635 bp PCR
product (instead of the 40,965 predicted) only from the
mother and son which indicated that the junction
was encompassed there (Additional file 1: Figure S4).Sequencing of PCR products from the mother and
the son revealed identical sequence where ChrX:
107,645,023 was next to ChrX:107,685,353 (chrX.hg19:g.
107,645,023_107,685,353del) (Fig. 4). The validated
CNV has been submitted to the Leiden Open (source)
Variation Database with REF numbers #0002653
(https://grenada.lumc.nl/LOVD2/COL4A/variants.php?
select_db=COL4A5&action=view&view=0002653) and
#0002654 (https://grenada.lumc.nl/LOVD2/COL4A/variants.
php?select_db=COL4A5&action=view&view=0002654).
Detection of gonosomal mosaicism
As the detection of the deletion was marginal in the ma-
ternal blood, we set out to investigate the possibility of
gonosomal mosaicism in the mother (Additional file 1).
Surprisingly, 3 heterozygous SNPs were detected
within the validated deleted region of the affected
mother (Additional file 1). These were subsequently
confirmed by Sanger sequencing. This observation
suggests maternal gonosomal mosaicism for the
COL4A5/6 deletion and explains the results of the
maternal blood DNA examination [12]. Indeed, the
intermediate level of signal observed across different
CNV detection techniques (SNP array, exome se-
quencing and Taqman CNV assay) indicated that the
maternal blood DNA used consisted of cells with two
copies of the COL4A5/6 region and cells with one
copy (Additional file 1: Figures. S1-S3).
Novel SNVs
The data generated by WES had an average coverage
(depth) of 90X with over 98 % of the targeted regions
exceeding 10X coverage (Additional file 1: Table S2). No
contamination signs were detected (Additional file 1:
Table S3). Sample relatedness check also indicated nor-
mal genetic sharing within the family.
Under a dominant model of inheritance, 38 putative
deleterious SNVs distributed among 37 genes were se-
lected (Additional file 1: Table S4). None of these SNVs
were present in the control populations or public exome
databases inspected. Among these 38 SNVs only shared
by the affected mother and son, we focused on 3 hetero-
zygous variants mapped to genes (AGTR1, COL6A3,
NOTCH2) that are associated with congenital disorders
whose phenotypic spectrum may include features that
could also be present in AS or DOL-AS (Table 1). The
three listed mutations were predicted “rare disease
causal” by the KGGSeq combined model.
AGTR1 (angiotensin II receptor, type 1) is associated
with renal tubular dysgenesis, an autosomal recessive
severe kidney disorder characterized by abnormal devel-
opment of the kidneys before birth. The stop-gain
mutation within AGTR1 (c.502C > T, p.R168*) would ter-
minate the protein at R168 halving the length of the
Fig. 4 Graphical presentation of previously reported COL4A5/6 deletions (case 1, current study; case 2 [5] , case 3 [4] , case 4 [3] in –a-). The
primer set used for accurate detection of the junctions found by Sanger sequencing of the 645b.p. product (b)
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already compromised in AS patients [13].
Interestingly, a mutation in a collagen gene (COL6A3)
(c.2782C > T, p.R928C) was identified. Collagen genes
encode structural proteins, collagens, which are the
major components of the extracellular matrices (ECMs)
of connective tissues. Thus, mutations in COL genes
result in a wide range of serious inherited disorders
(including AS) that although phenotypically diverse, they
may share similar disease mechanisms at molecular
level. COL6A3 mutations in particular are associated
with congenital muscular disorders such as Ullrich mus-
cular dystrophy and Bethlem myopathy which are char-
acterized by progressive skeletal muscle weakness. The
missense mutation identified, Arg928Cys, occurred in a
domain region of COL6A3 that if altered, the stability of
collagen monomers formed with alpha-1 and alpha-2
chains could affected [14–16].
NOTCH2 mutations are associated with Allagile
Syndrome and Hajdu-Cheney syndrome, two autosomal
dominant conditions. Importantly, a NOTCH2 mutation
has been reported in one case of Allagile Syndrome
(autosomal dominant disorder whose main feature is
bile duct paucity or even biliary atresia) where the
patient also had kidney dysfunction manifestations
including hematuria and proteinuria [17]. Likewise,
the NOTCH2 mutation(c.4758A > C, p.E1586D) iden-
tified in the index patient and his mother, could beTable 1 Top 3 deleterious snv identified by exome sequencing
Chr Gene Alleles Protein OMIM (#)
3 AGTR1 c.502C > T p.R168* Renal tubular dysgenesis, #267430
2 COL6A3 c.2782C > T p.R928C Bethlem myopathy, #158810
Ullrich congenital muscular
dystrophy, #254090
1 NOTCH2 c.4758A > C p.E1586D Alagille syndrome 2, #610205involved in kidney dysfunction although not such
sign has been observed.
We also investigated the presence of de novo muta-
tions in the index patient as we reasoned that the effect
of a maternally inherited mutation could be exacerbated
by de novo hits and this could account for the differ-
ences in the severity of the oesophageal leiomyomatosis
between mother and son. Only one de novo missense
SNVs was found in C9orf10, an annotated gene whose
function is unknown. This hypothesis was no longer
pursued.
Discussion
We have studied a family with one member (mother of
the index patient) affected with isolated diffused esopha-
geal leiomyomatosis (DOL) and another member (index
patient), affected with DOL-AS. Importantly, the renal
failure signs that characterize AS only appeared 2 years
and three months after the initial diagnosis of DOL. By
exome sequencing, genotyping array and PCR analysis of
patients’ DNA, we have identified a new 40 kb deletion
spanning from intron 2 of COL4A6 to intron 1 of
COL4A5. Deletions involving COL4A6/COL4A5 are only
found in individuals affected with DOL-AS and no mo-
lecular analyses were done on those few individuals with
isolated DOL reported in the literature [18–20]. The
boundaries of this newly identified deletion are in line
with those reported in patients with DOL-AS where the
deletion is limited to intron 1 and 2 of COL4A6. Dele-
tions whose boundary is beyond exon 3 of COL4A6 are
not seen in DOL-AS syndrome [21]. The affected
mother only expressed a mild and isolated DOL and
chose not to undergo esophagectomy. In contrast, the
son, who carries a hemizygous defective copy of the
COL4A6 gene had a more severe DOL phenotype and
esophagectomy was required. X-linked inheritance, to-
gether with maternal gonosomal mosaicim may explain
Liu et al. BMC Medical Genetics  (2015) 16:49 Page 7 of 8the phenotypic differences between mother and son.
This would be the first case of gonosomal mosaicism re-
ported in patients (mother) with DOL.
Another interesting fact in this study is the identifica-
tion, in the affected individuals, of potentially pathogenic
mutations in genes known to be involved in other severe
congenital disorders (Table 1) including other ECMs
disorders. Whether this mutations contribute to the ob-
served phenotype or may exacerbate it later is not
known. Noteworthy, a recent study of a five generation
family with AS identified a potential confounding variant
in the NPHS1 (nephrin) gene in addition to a COL4A5
mutation. Likewise, NPHS1 mutations are associated
with nephrotic syndromes and the authors speculate that
this mutation could modify the Alport Syndrome pheno-
type underlain by the COL4A5 mutation. This may well
be the case in the family reported here, yet mutations in
the three genes other than COL4A6 are all maternally
inherited. Whether the phenotypic differences between
affected mother and son result from the X-link inherit-
ance nature of AS, the gonosomal mosaicism or from
the effect of any of those mutations in those genes can-
not be assessed [22].
Conclusions
The family studied is the first case of a gonadosomal
mosaicism associated to DOL-AS.
Additional file
Additional file 1: Data analysis and variant calling.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WL: Surgical procedures, specimen collection and patient-follow up. JKLW:
Data analysis and manuscript writing, QH: Surgical procedures, specimen
collection and patient-follow up. E HMW: Data analysis, CSTT: Data analysis,
RZ: Laboratory work, MS: Laboratory work, KKYW: Clinical assessment and
pathological interpretation of the surgical specimens. JN: Clinical assessment
and pathological interpretation of the surgical specimens. SSC: Bioinformatics
input. PCS: Bioinformatics input and data analysis and interpretation, PKT: Clinical
assessment. M-M-B: study design, data interpretation and manuscript revision.
HX: Clinical assessment. All authors read and approved the final manuscript.
Acknowledgements
Support was obtained from The University of Hong Kong Genomics Strategic
Research Theme and the 2013 State Clinical key Speciality Construction
Project (Paediatric Surgery) No:GJLCZD1301.
Author details
1Department of Pediatric Surgery, Guangzhou Women and Children’s
Medical Center, Guangzhou, China. 2Department of Psychiatry, The University
of Hongkong, Hongkong, SAR, China. 3Department of Surgery, The University
of Hongkong, Hongkong, SAR, China. 4Department of Pathology, The
University of Hongkong, Hongkong, SAR, China. 5Center for Genomic
Sciences, The University of Hongkong, Hongkong, SAR, China. 6Centre for
Reproduction, Development, and Growth of the Li Ka Shing Faculty of
Medicine, Hong Kong, SAR, China. 7State Key Laboratory of Brain and
Cognitive Sciences, The University of Hong Kong, Hong Kong, SAR, China.Received: 17 November 2014 Accepted: 15 June 2015
References
1. Dahan K, Heidet L, Zhou J, Mettler G, Leppig KA, Proesmans W, et al.
Smooth muscle tumors associated with x-linked alport syndrome: carrier
detection in females. Kidney Int. 1995;48:1900–6.
2. Kruegel J, Rubel D, Gross O. Alport Syndrome–Insights from basic and
clinical research. Nat Rev Nephrol. 2013;9:170–8.
3. Segal Y, Peissel B, Renieri A, De Marchi M, Ballabio A, Pei Y, Zhou J.
Line-1 elements at the sites of molecular rearrangements in alport
syndrome-diffuse leiomyomatosis. Am J Hum Genet. 1999;64:62–9.
4. Thielen BK, Barker DF, Nelson RD, Zhou J, Kren SM, Segal Y. Deletion
mapping in alport syndrome and alport syndrome-diffuse leiomyomatosis
reveals potential mechanisms of visceral smooth muscle overgrowth. Hum
Mutat. 2003;22:419.
5. Oohashi T, Naito I, Ueki Y, Yamatsuji T, Permpoon R, Tanaka N, Naomoto Y,
Ninomiya Y. Clonal overgrowth of esophageal smooth muscle cells in
diffuse leiomyomatosis-alport syndrome caused by partial deletion in
col4a5 and col4a6 genes. Matrix Biol J Int Soc Matrix Biol. 2011;30:3–8.
6. Mothes H, Heidet L, Arrondel C, Richter KK, Thiele M, Patzer L, Sado Y,
Gubler MC, Antignac C, Scheele J. Alport syndrome associated with diffuse
leiomyomatosis: col4a5-col4a6 deletion associated with a mild form of
alport nephropathy. Nephrol Dialysis, Transplant Off Publication Eur
Dialysis Transplant Association - Eur Renal Assoc. 2002;17:70–4.
7. Ueki Y, Naito I, Oohashi T, Sugimoto M, Seki T, Yoshioka H, Sado Y,
Sato H, Sawai T, Sasaki F, et al. Topoisomerase i and ii consensus
sequences in a 17-kb deletion junction of the col4a5 and col4a6 genes
and immunohistochemical analysis of esophageal leiomyomatosis associated
with alport syndrome. Am J Human Genetics. 1998;62:253–61.
8. Sa MJ, Fieremans N, De Brouwer AP, Sousa R, Costa FT E, Brito MJ,
Carvalho F, Rodrigues M, De Sousa FT, Felgueiras J, et al. Deletion of the 5’exons
of col4a6 is not needed for the development of diffuse leiomyomatosis in
patients with alport syndrome. J Med Genetics. 2013;50:745–53.
9. Li MX, Gui HS, Kwan JS, Bao SY, Sham PC. A comprehensive framework for
prioritizing variants in exome sequencing studies of mendelian diseases.
Nucleic Acids Res. 2012;40:E53.
10. Li MX, Kwan JS, Bao SY, Yang W, Ho SL, Song YQ, Sham PC. Predicting
mendelian disease-causing non-synonymous single nucleotide variants
in exome sequencing studies. Plos Genet. 2013;9:E1003143.
11. Cooper GM, Goode DL, Ng SB, Sidow A, Bamshad MJ, Shendure J,
Nickerson DA. Single-nucleotide evolutionary constraint scores highlight
disease-causing mutations. Nat Methods. 2010;7:250–1.
12. Biesecker LG, Spinner NB. A genomic view of mosaicism and human
disease. Nat Rev Genet. 2013;14:307–20.
13. Yoshida T, Kato K, Fujimaki T, Yokoi K, Oguri M, Watanabe S, Metoki N,
Yoshida H, Satoh K, Aoyagi Y, et al. Association of genetic variants with
chronic kidney disease in japanese individuals. Clin J Am Soc Nephrol
CJASN. 2009;4:883–90.
14. Baker NL, Morgelin M, Pace RA, Peat RA, Adams NE, Gardner RJ, Rowland LP,
Miller G, De Jonghe P, Ceulemans B, et al. Molecular consequences of
dominant bethlem myopathy collagen vi mutations. Ann Neurol.
2007;62:390–405.
15. Bonnemann CG. The collagen vi-related myopathies: muscle meets its
matrix. Nat Rev Neurol. 2011;7:379–90.
16. Bateman JF, Boot-Handford RP, Lamande SR. Genetic diseases of connective
tissues: cellular and extracellular effects of ecm mutations. Nat Rev Genet.
2009;10:173–83.
17. Mcdaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, Piccoli DA,
Spinner NB. Notch2 mutations cause alagille syndrome, a heterogeneous
disorder of the notch signaling pathway. Am J Human Genetics.
2006;79:169–73.
18. Pujol J, Pares D, Mora L, Sans M, Jaurrieta E. Diagnosis and management of
diffuse leiomyomatosis of the oesophagus. Dis Esophagus Off J Int SocDis
Esophagus / ISDE. 2000;13:169–71.
19. Guevara G, O’connor E, Mccormack O, Harmon M, Finn S, Muldoon C,
Ravi N, Reynolds JV: Diffuse oesophageal leiomyomatosis. ANZ J
Surgery. 2013; doi: 10.1111/ans.12492.
20. Hoelscher AC, Hoelscher AH, Drebber U, Bludau M, Schroeder W.
Hereditary esophageal-vulvar syndrome. Ann Thoracic Surgery.
2012;94:E65–7.
Liu et al. BMC Medical Genetics  (2015) 16:49 Page 8 of 821. Heidet L, Dahan K, Zhou J, Xu Z, Cochat P, Gould JD, Leppig KA,
Proesmans W, Guyot C, Guillot M, et al. Deletions of both alpha 5(iv)
and alpha 6(iv) collagen genes in alport syndrome and in alport
syndrome associated with smooth muscle tumours. Hum Mol Genet.
1995;4:99–108.
22. Gibson J, Gilbert RD, Bunyan DJ, Angus EM, Fowler DJ, Ennis S.
Exome analysis resolves differential diagnosis of familial kidney
disease and uncovers a potential confounding variant. Genetics Res.
2013;95:165–73.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
